JP2015187157A5 - - Google Patents

Download PDF

Info

Publication number
JP2015187157A5
JP2015187157A5 JP2015126043A JP2015126043A JP2015187157A5 JP 2015187157 A5 JP2015187157 A5 JP 2015187157A5 JP 2015126043 A JP2015126043 A JP 2015126043A JP 2015126043 A JP2015126043 A JP 2015126043A JP 2015187157 A5 JP2015187157 A5 JP 2015187157A5
Authority
JP
Japan
Prior art keywords
administration
medicament
period
days
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015126043A
Other languages
English (en)
Japanese (ja)
Other versions
JP6153967B2 (ja
JP2015187157A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015187157A publication Critical patent/JP2015187157A/ja
Publication of JP2015187157A5 publication Critical patent/JP2015187157A5/ja
Application granted granted Critical
Publication of JP6153967B2 publication Critical patent/JP6153967B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2015126043A 2004-04-30 2015-06-23 延長されたホルモン避妊法における破綻出血の管理 Expired - Lifetime JP6153967B2 (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US56644304P 2004-04-30 2004-04-30
US60/566,443 2004-04-30
US57502404P 2004-05-28 2004-05-28
US60/575,024 2004-05-28
US57719904P 2004-06-07 2004-06-07
US60/577,199 2004-06-07
US63838004P 2004-12-27 2004-12-27
US60/638,380 2004-12-27
US66006805P 2005-03-10 2005-03-10
US60/660,068 2005-03-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012227416A Division JP6134491B2 (ja) 2004-04-30 2012-10-12 延長されたホルモン避妊法における破綻出血の管理

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016241318A Division JP2017048253A (ja) 2004-04-30 2016-12-13 延長されたホルモン避妊法における破綻出血の管理

Publications (3)

Publication Number Publication Date
JP2015187157A JP2015187157A (ja) 2015-10-29
JP2015187157A5 true JP2015187157A5 (OSRAM) 2016-07-07
JP6153967B2 JP6153967B2 (ja) 2017-06-28

Family

ID=35056905

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007509994A Withdrawn JP2007535519A (ja) 2004-04-30 2005-04-29 延長されたホルモン避妊法における破綻出血の管理
JP2012227416A Expired - Lifetime JP6134491B2 (ja) 2004-04-30 2012-10-12 延長されたホルモン避妊法における破綻出血の管理
JP2015126043A Expired - Lifetime JP6153967B2 (ja) 2004-04-30 2015-06-23 延長されたホルモン避妊法における破綻出血の管理
JP2016241318A Withdrawn JP2017048253A (ja) 2004-04-30 2016-12-13 延長されたホルモン避妊法における破綻出血の管理

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2007509994A Withdrawn JP2007535519A (ja) 2004-04-30 2005-04-29 延長されたホルモン避妊法における破綻出血の管理
JP2012227416A Expired - Lifetime JP6134491B2 (ja) 2004-04-30 2012-10-12 延長されたホルモン避妊法における破綻出血の管理

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016241318A Withdrawn JP2017048253A (ja) 2004-04-30 2016-12-13 延長されたホルモン避妊法における破綻出血の管理

Country Status (29)

Country Link
US (3) US8163721B2 (OSRAM)
EP (1) EP1747001B1 (OSRAM)
JP (4) JP2007535519A (OSRAM)
KR (4) KR20160150113A (OSRAM)
CN (1) CN103127156A (OSRAM)
AR (1) AR048722A1 (OSRAM)
AU (1) AU2005237255B2 (OSRAM)
BR (1) BRPI0510493A (OSRAM)
CA (1) CA2562296A1 (OSRAM)
CR (1) CR8709A (OSRAM)
DK (1) DK1747001T3 (OSRAM)
EA (2) EA031227B1 (OSRAM)
EC (1) ECSP066999A (OSRAM)
ES (1) ES2704999T3 (OSRAM)
HU (1) HUE041475T2 (OSRAM)
IL (1) IL178458A (OSRAM)
LT (1) LT1747001T (OSRAM)
MX (1) MXPA06012567A (OSRAM)
MY (1) MY151322A (OSRAM)
NO (1) NO341685B1 (OSRAM)
NZ (1) NZ586107A (OSRAM)
PA (1) PA8631801A1 (OSRAM)
PE (1) PE20060467A1 (OSRAM)
SG (2) SG152288A1 (OSRAM)
SI (1) SI1747001T1 (OSRAM)
SV (1) SV2006002100A (OSRAM)
TW (1) TWI374735B (OSRAM)
UY (1) UY28875A1 (OSRAM)
WO (1) WO2005105103A2 (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
MY151322A (en) 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US20070088010A1 (en) * 2005-10-17 2007-04-19 Doris Huebler Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest
EP1977752A1 (de) * 2007-03-01 2008-10-08 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Zubereitung zur Verminderung der Endometriose
DE102007011105A1 (de) * 2007-03-02 2008-09-04 Bayer Schering Pharma Aktiengesellschaft Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose
WO2010033188A2 (en) * 2008-09-16 2010-03-25 Playtex Products, Llc. Dosages for menstrual suppression, contraception, and hormone replacement therapy, and methods of administering same
US9198876B2 (en) 2008-10-08 2015-12-01 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
EP2343964A4 (en) 2008-10-08 2012-11-07 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
EP2343979B1 (en) 2008-10-08 2020-04-08 Agile Therapeutics, Inc. Transdermal delivery
EP2410859A4 (en) 2009-03-27 2013-03-13 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US10849857B2 (en) 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US9603860B2 (en) 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
JP6866560B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
MA44206B1 (fr) 2015-06-18 2021-04-30 Estetra Sprl Comprimé orodispersible comprenant estetrol
JP6863547B2 (ja) 2015-06-18 2021-04-21 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
LT3310345T (lt) 2015-06-18 2021-06-25 Estetra Sprl Burnoje disperguojama tabletė, turinti estetrolio
CN108025014B (zh) * 2015-06-23 2021-10-22 莱昂实验室制药股份有限公司 用于过重女性患者的基于屈螺酮的避孕药
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
WO2018060501A2 (en) 2016-09-30 2018-04-05 Myovant Sciences Gmbh Methods of treating uterine fibroids and endometriosis
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US12138270B2 (en) 2021-09-07 2024-11-12 Millicent Pharma Limited Contraceptive regimen including reduced level of estrogen

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244096A (en) * 1988-04-22 1993-09-14 Stoner Fred L Preventive treatment kit against sexually transmitted disease
AU3473193A (en) 1992-01-17 1993-08-03 Procter & Gamble Company, The Treatment for atherosclerosis
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6451778B1 (en) * 1996-07-26 2002-09-17 Wyeth Oral contraceptive
EP0956024B1 (en) * 1996-07-26 2004-07-21 Wyeth Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen
US5842441A (en) 1996-08-26 1998-12-01 Pharmalett Denmark A/S Medicated and individualized treatment shampoo for dermatological disturbances of companion animals
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
RS50262B2 (sr) 1999-08-31 2018-10-31 Bayer Pharma AG Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
CO5271709A1 (es) * 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos
US6653298B2 (en) * 2000-01-14 2003-11-25 Sterix Limited Composition
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
TWI303990B (en) * 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health
US20020193356A1 (en) * 2001-05-23 2002-12-19 Van Beek Agatha Antonia Magdalena Means and method for hormonal contraception
US20030018018A1 (en) 2001-07-10 2003-01-23 Medical College Of Hampton Roads Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
US8501720B2 (en) * 2004-07-30 2013-08-06 Bayer Pharma AG Method for treatment of dysmenorrhea

Similar Documents

Publication Publication Date Title
JP2015187157A5 (OSRAM)
JP2013018787A5 (OSRAM)
JP2018193377A5 (OSRAM)
JP2015038149A5 (OSRAM)
JP2010180236A5 (OSRAM)
JP2013155188A5 (OSRAM)
JP2012193216A5 (OSRAM)
JP2015038135A5 (OSRAM)
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
JP2017506624A5 (OSRAM)
JP2016185995A5 (OSRAM)
JP2013529665A5 (OSRAM)
JP2021509395A5 (OSRAM)
JP2017512194A5 (OSRAM)
JP2017507142A5 (OSRAM)
MX2018000084A (es) Una composicion farmaceutica que comprende amlodipino, valsartan y rosuvastatina.
RU2018146504A (ru) Лечение внутрипеченочных холестатических заболеваний
JP2016505050A5 (OSRAM)
JP2019507786A5 (OSRAM)
JP2021505669A5 (OSRAM)
JP2019529569A5 (OSRAM)
JP2017061488A5 (OSRAM)
JP2013047269A5 (OSRAM)
JP2017530142A5 (OSRAM)
JP2018505901A5 (OSRAM)